Pau Badia-I-Mompel

Pau Badia-I-Mompel

Auto-generated profile, based on publicly available information

Pau Badia-I-Mompel

Heidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Bioinformatics Advances
Verified
Journal Article
Open access
PDF file
PBPau Badia-I-Mompel
Pau Badia-I-Mompel
JSJesús Vélez Santiago
Jesús Vélez Santiago
JBJana Braunger
Jana Braunger
CGCelina Geiss
Celina Geiss
DDDaniel Dimitrov
Daniel Dimitrov
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
Many methods allow us to extract biological activities from omics data using information from prior knowledge resources, reducing the dimensionality for increased statistical power and better interpretability. Here, we present decoupleR, a Bioconductor and Python package containing computational methods to extract these activities within a unified framework. decoupleR allows us to flexibly run any method with a given resource, including methods that leverage mode of regulation and weights of interactions, which are not present in other frameworks. Moreover, it leverages OmniPath, a meta-resource comprising over 100 databases of prior knowledge. Using decoupleR, we evaluated the performance of methods on transcriptomic and phospho-proteomic perturbation experiments. Our findings suggest that simple linear models and the consensus score across top methods perform better than other methods at predicting perturbed regulators. decoupleR’s open-source code is available in Bioconductor (https://www.bioconductor.org/packages/release/bioc/html/decoupleR.html) for R and in GitHub (https://github.com/saezlab/decoupler-py) for Python. The code to reproduce the results is in GitHub (https://github.com/saezlab/decoupleR_manuscript) and the data in Zenodo (https://zenodo.org/record/5645208). Supplementary data are available at Bioinformatics Advances online.

26 June 2023 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
PBPau Badia-I-Mompel
Pau Badia-I-Mompel
LWLorna Wessels
Lorna Wessels
SMSophia Müller-Dott
Sophia Müller-Dott
RTRémi Trimbour
Rémi Trimbour
RFRicardo O. Ramirez Flores
Ricardo O. Ramirez Flores
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez

16 October 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
SMSophia Müller-Dott
Sophia Müller-Dott
ETEirini Tsirvouli
Eirini Tsirvouli
MVMiguel Vazquez
Miguel Vazquez
RFRicardo O Ramirez Flores
Ricardo O Ramirez Flores
PBPau Badia-I-Mompel
Pau Badia-I-Mompel
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
Gene regulation plays a critical role in the cellular processes that underlie human health and disease. The regulatory relationship between transcription factors (TFs), key regulators of gene expression, and their target genes, the so called TF regulons, can be coupled with computational algorithms to estimate the activity of TFs. However, to interpret these findings accurately, regulons of high reliability and coverage are needed. In this study, we present and evaluate a collection of regulons created using the CollecTRI meta-resource containing signed TF–gene interactions for 1186 TFs. In this context, we introduce a workflow to integrate information from multiple resources and assign the sign of regulation to TF–gene interactions that could be applied to other comprehensive knowledge bases. We find that the signed CollecTRI-derived regulons outperform other public collections of regulatory interactions in accurately inferring changes in TF activities in perturbation experiments. Furthermore, we showcase the value of the regulons by examining TF activity profiles in three different cancer types and exploring TF activities at the level of single-cells. Overall, the CollecTRI-derived TF regulons enable the accurate and comprehensive estimation of TF activities and thereby help to interpret transcriptomics data.

2 September 2024 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
DDDaniel Dimitrov
Daniel Dimitrov
PSPhilipp Sven Lars Schäfer
Philipp Sven Lars Schäfer
EFElias Farr
Elias Farr
PRPablo Rodriguez-Mier
Pablo Rodriguez-Mier
SLSebastian Lobentanzer
Sebastian Lobentanzer
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
The growing availability of single-cell and spatially resolved transcriptomics has led to the development of many approaches to infer cell–cell communication, each capturing only a partial view of the complex landscape of intercellular signalling. Here we present LIANA+, a scalable framework built around a rich knowledge base to decode coordinated inter- and intracellular signalling events from single- and multi-condition datasets in both single-cell and spatially resolved data. By extending and unifying established methodologies, LIANA+ provides a comprehensive set of synergistic components to study cell–cell communication via diverse molecular mediators, including those measured in multi-omics data. LIANA+ is accessible at https://github.com/saezlab/liana-py with extensive vignettes (https://liana-py.readthedocs.io/) and provides an all-in-one solution to intercellular communication inference.

28 March 2022 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
NWNicola Wanner
Nicola Wanner
GAGeoffroy Andrieux
Geoffroy Andrieux
PBPau Badia-I-Mompel
Pau Badia-I-Mompel
CECarolin Edler
Carolin Edler
SPSusanne Pfefferle
Susanne Pfefferle
THTobias B. Huber
Tobias B. Huber
Extrapulmonary manifestations of COVID-19 have gained attention due to their links to clinical outcomes and their potential long-term sequelae1. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) displays tropism towards several organs, including the heart and kidney. Whether it also directly affects the liver has been debated2,3. Here we provide clinical, histopathological, molecular and bioinformatic evidence for the hepatic tropism of SARS-CoV-2. We find that liver injury, indicated by a high frequency of abnormal liver function tests, is a common clinical feature of COVID-19 in two independent cohorts of patients with COVID-19 requiring hospitalization. Using autopsy samples obtained from a third patient cohort, we provide multiple levels of evidence for SARS-CoV-2 liver tropism, including viral RNA detection in 69% of autopsy liver specimens, and successful isolation of infectious SARS-CoV-2 from liver tissue postmortem. Furthermore, we identify transcription-, proteomic- and transcription factor-based activity profiles in hepatic autopsy samples, revealing similarities to the signatures associated with multiple other viral infections of the human liver. Together, we provide a comprehensive multimodal analysis of SARS-CoV-2 liver tropism, which increases our understanding of the molecular consequences of severe COVID-19 and could be useful for the identification of organ-specific pharmacological targets.

24 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBMartino Bertoni
Martino Bertoni
MDMiquel Duran-Frigola
Miquel Duran-Frigola
PBPau Badia-I-Mompel
Pau Badia-I-Mompel
EPEduardo Pauls
Eduardo Pauls
MOModesto Orozco-Ruiz
Modesto Orozco-Ruiz
PAPatrick Aloy
Patrick Aloy
Chemical descriptors encode the physicochemical and structural properties of small molecules, and they are at the core of chemoinformatics. The broad release of bioactivity data has prompted enriched representations of compounds, reaching beyond chemical structures and capturing their known biological properties. Unfortunately, bioactivity descriptors are not available for most small molecules, which limits their applicability to a few thousand well characterized compounds. Here we present a collection of deep neural networks able to infer bioactivity signatures for any compound of interest, even when little or no experimental information is available for them. Our signaturizers relate to bioactivities of 25 different types (including target profiles, cellular response and clinical outcomes) and can be used as drop-in replacements for chemical descriptors in day-to-day chemoinformatics tasks. Indeed, we illustrate how inferred bioactivity signatures are useful to navigate the chemical space in a biologically relevant manner, unveiling higher-order organization in natural product collections, and to enrich mostly uncharacterized chemical libraries for activity against the drug-orphan target Snail1. Moreover, we implement a battery of signature-activity relationship (SigAR) models and show a substantial improvement in performance, with respect to chemistry-based classifiers, across a series of biophysics and physiology activity prediction benchmarks.